About 80% of patients treated with cyclosporine develop cutaneous adverse effects.1 These include manifestations of excessive epithelial proliferation: hypertrichosis, gingival hypertrophy, hyperplastic pseudofolliculitis barbae, pilar keratosis, epidermal (follicular infundibular) cysts, sebaceous gland hyperplasia, and, as recently described,2 folliculodystrophy syndrome. We report a case of tufted folliculitis of the scalp in a patient who was treated with cyclosporine.
Farhi D, Buffard V, Ortonne N, Revuz J. Tufted Folliculitis of the Scalp and Treatment With Cyclosporine. Arch Dermatol. 2006;142(2):251–252. doi:10.1001/archderm.142.2.251
Customize your JAMA Network experience by selecting one or more topics from the list below.